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Abstract 
 
The Impact of Computerized Provider Order Entry (CPOE) on Medication Order 
Processing and Workflow Efficiency by Pharmacists:  
A Time and Motion Study 
 
Introduction:  Recently, there has been a tremendous increase in the preparation on 
the part of US hospitals to implement CPOE.  Employer groups, the federal government, 
and others have been advocating its implementation since the early 2000s, yet the 
number of hospitals which have met meaningful use criteria for CPOE is still less than 
15%.  This number is projected to increase exponentially in a very short time, spurred by 
incentives from the Centers for Medicare and Medicaid (CMS).  With such a large 
amount of hospitals preparing for CPOE implementation, there is still much to learn 
about the impact of these systems.  The objective of this study is to quantify the change 
in pharmacist workflow after CPOE is implemented. 
Methods:  An experimental, enhanced pretest-posttest, prospective, time and motion 
study was conducted in four inpatient pharmacies within the same hospital system.  
Order entry pharmacists were observed for two separate time periods.  The 
intervention pharmacy was observed first as a non-CPOE pharmacy and then later, after 
CPOE had been implemented.  There was a control pharmacy which was non-CPOE for 
both time periods.  There were two treatment control pharmacies, both of which had 
CPOE for both time periods. 
A database instrument recorded 37 different pharmacist tasks, which were 
grouped into four activities: clinical, distributive, administrative, and miscellaneous.  
 viii 
 
Comparisons of the amount of time spent by the order entry pharmacist in each of the 
four different activities were conducted.  SAS® version 9.3 was used to analyze the data, 
with statistical significance set at 0.05. 
Results:  A total of 114 hours at the non-CPOE site and 197 hours at the CPOE site met 
the inclusion criteria.  Non-parametric linear regressions were modeled and the 
predicted values were analyzed.  The predicted mean number of minutes for each 
recorded hour were, by activity (predicted mean ± SD for non-CPOE versus CPOE, p-
value): clinical (5.10 ± 2.24 versus 3.83 ± 1.34, p<0.05); distributive (44.55 ± 1.07 versus 
47.61 ± 1.43, p<0.05); administrative (7.25 ± 2.34 versus 6.67 ± 1.28, p<0.05); and 
miscellaneous (3.11 ± 0.77 versus 1.89 ± 0.68, p<0.05). 
Conclusions:  Less time was spent in the clinical, administrative, and miscellaneous 
activities, while more time was spent in the distributive activity after CPOE 
implementation.  These findings were statistically significant. 
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Chapter 1 
Introduction 
This chapter will serve as an introduction to computerized provider order entry 
(CPOE), including a history of CPOE and its future.  The purpose and objectives of the 
study will be outlined at the end of the chapter. 
 
Technological Advances in the Inpatient Pharmacy 
 Over the years, there have been many technological advances in the inpatient 
pharmacy.  Following are a few examples of some of the recent technologies which have 
been introduced to the inpatient pharmacy:  automated dispensing cabinets, carousel 
drug storage units, high speed barcode packaging devices, robotic dispensing devices, 
robotic IV preparation devices, barcode medication administration (BCMA) systems, and 
intelligent IV infusion pump technology (Brookins, Burnette, De la Torre et al. 2011).  All 
of these technologies aim to ultimately improve the outcome of the patient, either 
directly or indirectly.  They also serve an added benefit of reducing the workload on the 
pharmacist by improving productivity through automated technology. 
 With the advent of electronic medical records (EMR), the pharmacist is able to 
easily view a patient’s chart without having to leave the central pharmacy or make a call 
to the nurse station.  Having a single record for a patient which can be modified by 
those who are qualified and have access is a powerful tool.  For the pharmacist, it means 
having almost immediate access to information which will lead to more informed 
decisions. 
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 Computerized provider order entry (CPOE) is yet another technology which holds 
a lot of promise in terms of improving patient safety.  It may also help with improving 
the productivity of the pharmacist. 
 
CPOE Defined 
CPOE has been defined as “computerized provider order entry”, “computerized 
prescriber order entry”, “computerized physician order entry”, and “computerized 
pharmacist order entry”.  This study uses the definition used by meaningful use 
terminology when referring to CPOE, which is “computerized provider order entry”. 
CPOE is the electronic entry of orders by an authorized provider, such as the 
physician or a nurse on behalf of the physician (Young 2003).  These orders were 
traditionally handwritten and communicated to the pharmacy by one of many methods 
for dispensing.  With the advent of a CPOE system, a provider will directly enter the 
orders into the computer.  These orders are typically available to the pharmacist for 
verification virtually immediately upon completion by the provider. 
 At the very least, CPOE eliminates the need for a pharmacist to interpret the 
provider’s handwriting and subsequently enter the order into the computer.  Indeed, 
this is a tremendous benefit to the pharmacist who has traditionally been on the 
receiving end of some orders which are very difficult to interpret.  Such was the case in 
the unfortunate demise of a cardiac patient in a Texas hospital due directly to the 
understandable misinterpretation of a physician’s handwritten order on the part of the 
pharmacist (Glabman 2005).  The physician was found liable in the court system.  
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Indeed, as of 2005, six states had passed laws requiring physicians to write orders which 
are legible (Glabman 2005). 
 More than just a tool used to eliminate the potentially devastating effect of 
cacography, or illegibility of poor handwriting, CPOE improves safety in other ways, 
depending on the level of sophistication of the system.  The first is that the orders are 
structured, meaning the provider typically must include the dose, route, and frequency.  
The second is that the provider can be easily identified, which allows for easy follow-up, 
if necessary.  Third, the provider has information readily available throughout the 
prescribing process.  This can include patient medical records, lab results, allergy 
information, customized order sets, and clinical decision support systems (CDSS) (Bates 
2000). 
 Order sets are defined as standardized medication and procedure orders (Hoey, 
Nichol, and Silverman 2009).  They are designed to facilitate the entry of multiple orders 
for standardized purposes.  They are the electronic version of the pre-printed paper 
order forms. 
 As defined in an article by Ash, McCormack, Sittig et al, clinical decision support 
(CDS) refers to “passive and active referential information as well as computer-based 
order sets, reminders, alerts, and condition (-specific) or patient-specific data displays 
that are accessible at the point of care” (Ash, McCormack, Sittig et al. 2012).  Among 
other things, CDS provides guidelines for Best Practices to the provider as the order is 
entered. 
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 Additionally, CPOE is integrated with the electronic medication administration 
record (E-MAR) and the electronic health record (EHR), allowing for real-time 
information availability to the provider.  Patient scheduling, billing, and hospital 
inventory are also integrated with the system.   
CPOE systems vary greatly in capability and cost, depending on the capability of 
the system.  In 2003, First Consulting Group, in a report for the American Hospital 
Association and the Federation of American Hospitals, performed a case study of five 
hospitals (Young 2003).  They found that the total one-time capital and operating costs 
for the implementation of CPOE averaged $12 million, with a range between $6.3 
million and $27.3 million. 
 
Why CPOE 
 CPOE has become the goal of many entities.  The federal government, 
specifically the Centers for Medicare and Medicaid (CMS) and the Agency for Healthcare 
Research and Quality (AHRQ), the Leapfrog Group, and hospitals all across the country 
have listed the implementation of CPOE as one of their top priorities.  This is due to 
many factors, but chiefly patient safety. 
 In 1999, the Institute of Medicine released the landmark publication To Err is 
Human: Building a Safer Health System (Kohn, Corrigan, and Donaldson 1999).  This 
writing shed light on the severity of the problem facing the nation’s healthcare system.  
It was found that of the 33.6 million hospital admissions in 1997, there were 98,000 
deaths, of which 7,000 were due to medication errors. 
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 Moreover, on average, each hospital patient was exposed to one medication 
error per day (Young 2006).  The widespread effect of this data energized the combined 
efforts of those in both the public and private sectors to find solutions to the alarming 
problem.  For reasons which will be outlined in subsequent sections, CPOE became a 
large part of the multi-faceting approach targeting the source of the safety issue. 
 Another secondary factor which pointed to CPOE as a possible solution dealt 
with the economic concerns of the nation.  The CMS budget for the year 2019 was 
estimated to increase to 6% of the national gross domestic product (GDP) (IOM 2010).  
By the year 2050, that figure was projected to double. 
 Preventable adverse drug events (ADEs) were found to cost between $17 to $19 
billion in 1999 (Kohn, Corrigan, and Donaldson 1999).  This translated to approximately 
$4,700 added to the cost of each hospital admission. 
 Studies had shown the potential for CPOE to reduce these medication errors, 
thereby bettering patient outcomes and consequently lowering healthcare costs.  Even 
as far back as the 1960’s, it had been advocated to have the physician enter an order 
directly into the computer, in order to ensure quality outcomes (Sittig and Stead 1994).  
One of the first hospitals to implement a version of CPOE was the El Camino Hospital in 
Mountain View, CA.  After implementation, omission errors in medication orders were 
significantly decreased (Sittig and Stead 1994).  Similar findings have been discovered 
since the El Camino Hospital study, and will be discussed in the Medication Safety 
section. 
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History of CPOE 
Early Beginnings 
CPOE was born from the idea that patient safety could be improved if the 
interpretation of a physician’s handwriting could be minimized or eliminated.  To that 
end, it was developed and has been around in one form or another since the late 1960s.  
El Camino Hospital is credited with implementing one of the first CPOE systems (Sittig 
and Stead 1994).  The National Center for Health Services research selected El Camino 
Hospital to test the recently-developed Tehnicon Medical Information Management 
System.  The results were positive.  Prescription omission errors of site and route of 
medication administration fell from 7.9% to less than 0.5% (p<0.01) as well as dosage 
scheduling errors were reduced from 1.3% to less than 0.5% (p<0.01). 
Time passed and improvements were made, but it wouldn’t be until the end of 
the last century that CPOE would really begin to accelerate in terms of widespread 
implementation and acceptance. 
 
CPOE Takes Off 
 To Err is Human truly brought to the fore the challenges facing the U.S. 
healthcare system for both those in the health care profession as well as the layperson 
(Kohn, Corrigan, and Donaldson 1999).  These statistics became a real signal to the 
profession that systematic change needed to take place.  In To Err is Human, the 
Institute of Medicine emphasized that whenever humans are involved, processes are 
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subject to failure.  However, changes to the processes themselves can alleviate the 
effect of potential errors. 
In 1995, the Leape study was published (Leape, Bates, Cullen et al. 1995), 
focusing on 5 distinct errors of the medication use process.  CPOE would prove to 
address each of these, either directly or indirectly: 
1. Prescribing.  Numerous features would become available to the provider, 
including: prescribing error prevention capabilities, clinical decision 
support with alerts, and guidelines for best practices. 
2. Transcribing and Documentation.  Inherent to CPOE, the pharmacist will 
no longer have to interpret handwriting.  Additionally, the order would 
automatically become part of the electronic health record (EHR). 
3. Dispensing.  The act of ensuring that the correct medication is pulled 
from inventory, aided by CPOE in that the medication which was 
prescribed by the physician and verified by the pharmacist is the one 
which is automatically made available to the technician or nurse for 
delivery to the patient. 
4. Administration.  The actual administration of the medication, typically by 
the nurse, is verified through the CPOE system through the scanning of 
the medication barcode and the scanning of the patient’s identification 
wristband barcode. 
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5. Monitoring.  The CPOE system is integrated with the EHR which allows for 
real time monitoring of the patient by the clinicians involved with the 
patient. 
The Leapfrog Group was, and continues to be, an instrumental player in 
advocating for the implementation of CPOE (Kilbridge, Welebob, and Classen 2006).  It 
was created in response to the research in To Err is Human in November 1999.  The 
group started as a consortium of large healthcare purchasers charged with the mission 
of making “great leaps forward” in the safety and quality of the nation’s healthcare.  At 
the top of the group’s list of goals was the recommendation of the implementation of 
CPOE, specifically to address the improvement of patient safety by reducing the 
potential for harm in medication use.  Since then, the group has added another 27 safe 
practice objectives. 
 
Direction of CPOE 
 Since 2000, there have been concerted efforts to assess the progress of hospitals 
all across the nation with regards to the implementation of CPOE.  The question has 
arisen as to what constitutes acceptable CPOE, since there are a wide range of criteria.  
The Leapfrog Group proposed a set of criteria and in 2002, assessed that 2% of US 
hospitals had implemented qualified CPOE systems (Leapfrog Group 2012).  By 2008, the 
group found that 8% of US hospitals had implemented qualified CPOE systems. 
More recently, the Health Information Technology for Economic and Clinical 
Health Act (HITECH) of 2009 was passed as a part of the American Recovery and 
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Reinvestment Act of 2009 in an effort to aid with improving patient outcomes and 
ultimately reducing healthcare costs with the implementation of technological 
efficiencies (ARRA 2009).   A key feature of the act was that it brought about incentives 
for hospitals to implement electronic health records (EHR) with “meaningful use” 
through CMS (CMS 2012). 
Despite this trend, according to the HIMSS AnalyticsTM Database, as of the third 
quarter of 2012, there are still only 14.2% of US hospitals which were compliant with 
Stage 4 (part of a separate rating scale for EHR and CPOE implementation which is now 
the industry accepted criteria), which includes the implementation of a CPOE system 
with meaningful use (HIMSS Analytics 2012).  This implies that there are still many 
hospitals that have not yet transitioned fully into CPOE systems.    Table 1 displays the 
progress which has been made on behalf of the US, according to the current EMR 
Adoption Model, relating to the metrics of “meaningful use”.  
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Table 1.  US EMR Adoption (HIMSS Analytics 2012) 
 
With hospitals and pharmacies implementing CPOE at such a rapid rate, 
pharmacy leadership will be forced to reexamine pharmacy workflow in order to remain 
productive. 
 
Study Purpose & Significance 
 The purpose of this study is to assess the impact of a technological intervention 
(namely CPOE) on the workflow processes of pharmacists.  The significance of this study 
is aimed at helping the pharmacist and pharmacy management better understand the 
impact of the implementation of a CPOE system on pharmacist workflow. 
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Study Objective 
 The objective of this research is to perform a time and motion study to quantify 
the amount of time which an inpatient order entry pharmacist spends on various 
activities in a non-CPOE versus a CPOE implementation setting. 
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Chapter 2 
Literature Review and Theory 
This chapter will explore the background of where CPOE has come from and its 
future direction.  Following is an extensive review of the current literature on CPOE, by 
major category, specifically: 1) Clinical decision support and Order sets; 2) Meaningful 
Use; 3) Medication Safety; 4) Unintended Consequences; 5) Order Turn-Around-Time; 
and 6) Time and Motion Comparisons.  Past studies will be referenced which have 
relevance to this study.  The chapter will end with the theory used as a guideline and its 
application to this study. 
 
CPOE Literature 
 Much has been written about CPOE, particularly in the last decade.  The systems 
have evolved, but in the light of all medical technological interventions, are still very 
much in the infant stage.  The following literature review is intended to provide an 
overview of the broad topics regarding CPOE and its implementation. 
 
Clinical Decision Support and Order Sets 
 As mentioned earlier, clinical decision support (CDS) refers to “passive and active 
referential information as well as reminders, alerts, and guidelines” (Ash, Sittig, 
Campbell et al. 2007).  Among other things, CDS provides guidelines for best practices to 
the provider as the order is entered.  The complexity of these systems is quite 
impressive.  Such systems can provide alerts and warnings in the event that a potential 
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drug allergy is detected, if a dose is out of range of the accepted clinical guidelines, if a 
drug-drug interaction is possible, or if a patient’s vital statistics needs to be updated, 
just to name a few examples.  Considering the sheer number of different factors which 
can play a role in the ultimate decision by the clinician, a CDS system needs to account 
for any amount of variation from patient to patient.  All this needs to be done in the 
context of giving relevant information, without deluging the provider with too much 
information.  This is a daunting task. 
 In 2004, an expert panel conference was held to identify the unintended 
consequences of clinical decision support coupled with CPOE (Ash, Sittig, Campbell et al. 
2007).  While acknowledging the need and overall benefits of CDS, they found that there 
were three major themes which still need to be addressed regarding CDS: 
1. Elimination or shifting of human roles.  For example, the CDS required the 
physicians to enter a dose, yet the CDS was sometimes found to be inadequate.  
As advances are made with CDS, less involvement of the pharmacist could arise 
regarding dosing inquires. 
2. Currency of CDS content.  In the effort to maintain compliance with CMS or 
JCAHO, some of these hospitals struggled to update their CDS content. 
3. Wrong or misleading CDS content.  When some new CDS module updates are 
incorporated with existing systems, some orders are generated for items which 
are not in the inventory.  There are cases when alerts are inappropriate, or other 
cases when information cannot be trusted. 
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In summary, the authors concluded, “While these unintended consequences 
could be avoided completely if no CDS is implemented, CPOE cannot offer the benefits 
that can lead to safety improvements” (Ash, Sittig, Campbell et al. 2007). 
Order sets are defined as standardized medication and procedure orders.  They 
are designed to facilitate the entry of multiple orders for standardized purposes (Hoey, 
Nichol, and  Silverman 2009).  They are the electronic version of the pre-printed paper 
order forms. 
In a recent article, an experimental project was conducted using order sets in a 
pediatric surgery setting (Avansino and Leu 2012).  The purpose was to determine if a 
systematically developed order set provides better usability or decreased cognitive 
workload on the part of the provider over an ad hoc developed order set.  It was found 
that among the seven surgeons who participated, they unanimously preferred the 
systematically developed order sets, by reducing the cognitive workload on the part of 
the provider and reducing the order variation.  This finding is important in view of 
findings by AHRQ that there can be a reluctance on the part of the provider in changing 
from paper-based prescribing to CPOE, which has led to low usage rates of CPOE 
(McDonnell, Werner, and Wendel 2010).   
 
Meaningful Use 
 In 2009, the American Recovery and Reinvestment Act was passed by Congress 
(ARRA 2009).  This act included the Health Information Technology for Economic and 
Clinical Health (HITECH) act as well.  The HITECH act was a tremendous commitment on 
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the part of the government to advance health care technology.  It allowed for CMS to 
pay incentives to hospitals for proven “meaningful use” with regard to their information 
systems. 
Currently, there are two stages, each having 16 objectives, which have been 
clearly defined by CMS, with a third stage still to be defined (HealthIT 2012).  Note that 
this CMS stage system is a different stage system than that of HIMSS Analytics outlined 
earlier.  Stage 1 (termed “Data capture and sharing”) requires that more than 30% of all 
patients have at least one medication order entered with CPOE, among other items.  A 
Stage 2 (termed “Advance clinical processes”) requirement is for over 60% of all 
medication orders to be entered with CPOE.  Another Stage 2 requirement is for the 
implementation of five clinical decision support interventions related to four or more 
clinical quality measures, in addition to drug-drug and drug-allergy alerts.   Stage 3 is 
termed “Improved outcomes” and will be ratified in the near future.   
If a hospital can prove meaningful use for these stages by the timeline specified, 
then they will receive incentives which can translate to millions of dollars for those years 
(Laegeler 2012). 
 
Medication Safety 
 In 2000, an article by Bates related some of the staggering statistics for the time 
(Bates 2000).  The article established that there was an overall incidence of 6.7% for 
serious adverse drug reactions in hospitals.  It was estimated that between 28% and 
56% of adverse drug reactions are preventable.  The article further lists many of the 
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technological interventions as having the potential to greatly reduce these statistics.  At 
the top of the list was CPOE, namely for the cited findings of another study, which 
stated that even a simple CPOE system was found to reduce medication errors by 64%. 
 A study performed at St. Luke’s Episcopal Hospital in 2006 explored whether 
there was a difference between the number of medication errors in using a non-CPOE 
versus a CPOE system (Abbass, Mhatre, Sansgiry et al. 2011).   The findings were clear.  
Of the 1,110 orders reviewed, there were a total of 135 medication errors.  The non-
CPOE system rendered 117 errors versus 18 for the CPOE system. 
 The Leapfrog Group estimated in 2008 that CPOE systems could reduce the 
number of ADEs in the US alone by up to 88% (Leapfrog Group 2008).  This translated to 
an estimated prevention of three million serious medication errors each year. 
 It is clear that CPOE has the potential to prevent many medication errors.  These 
references echo many other similar studies focused on the benefits of implementing 
CPOE in terms of patient outcomes alone. 
  
Unintended Consequences 
 As with any medical technological intervention, there are cautionary results as 
well.  Many researchers have warned that CPOE is still far from being fully developed.  
Unintended consequences of the implementation of CPOE are also documented. 
 One of the most comprehensive studies into this phenomenon was published in 
2009 (Ash, Sittig, Dykstra et al. 2009).  This project involved four years of research 
specifically into the unintended consequences of CPOE.  There were 380 examples of 
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unintended consequences which were analyzed and grouped into the following nine 
categories: 
1. More / New work issues 
2. Workflow issues 
3. Never ending demands 
4. Paper persistence 
5. Communication issues 
6. Emotions 
7. New kinds of errors 
8. Changes in the power structure 
9. Overdependence on technology 
There was a case which unexpectedly found an alarming outcome in Children’s 
Hospital of Pittsburgh (CHP), a tertiary care pediatric facility (Han, Carcillo, 
Venkataraman et al. 2005).  The study population included 1,942 children who were 
referred and admitted to CHP over an 18 month period, from October 2001 to March 
2003.  Of those patients, 75 died, which was an overall mortality rate of 3.86%.  The 
mortality rate was found to have increased from 2.80% pre-CPOE to 6.57% post-CPOE 
implementation.  Even after multivariate analysis, CPOE remained independently 
associated with increased mortality, after adjusting for other mortality covariates.  The 
authors warned of the possibility that even though ADEs at their facility were reduced, 
this cannot directly translate into reduced mortality. 
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A recent article in the New England Journal of Medicine portrays a growing 
concern about electronic health records (EHR) as a whole (Sittig and Singh, 2012).  Since 
2008, the number of certified EHR vendors in the US has increased by over 16 times (60 
companies as of 2008 to over 1000 as of 2012).  The authors proceed to offer a three-
phase model to encourage the development of EHR-specific patient safety goals (e-
PSGs): 1) Address safety concerns unique to EHR technology; 2) Mitigate safety concerns 
arising from failure to use EHR’s appropriately; and 3) Use EHR’s to monitor and 
improve patient safety.  This proposal creates a strategy aimed at addressing patient 
safety issues specifically regarding EHR. 
 These systems are as sophisticated and complex as they come, both in the 
medical field or elsewhere, and they require a certain amount of resources to 
implement and maintain.  Indeed, one estimate of maintaining a CPOE system at a 500 
bed hospital was $1.35 million annually (Wietholter 2009). 
Certainly, in the wake of such a rapid adoption of CPOE by such a large number 
of hospitals in a relatively short amount of time, experts caution of the importance of 
constant vigilance to protect the safety of the patient.  Indeed, just because a process is 
automated does not, by itself, make it necessarily safer than the original process (CPOE 
2003).   
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Order Turn-Around Time 
 In the pharmacy, medication order turn-around time (TAT) is the amount of time 
from when the order is received in the pharmacy to the time that the order is verified by 
the pharmacist.   
At the Pitt County Memorial Hospital in Greenville, NC, TAT was reduced by 90% 
after the implementation of CPOE (Wietholter, Sitterson, and Allison 2009).  Similarly, 
TAT was reduced by: 83.4% at Denver Health Medical Center in Denver, CO (Steele and 
DeBrow 2008); and 71% at Providence Portland Medical Center in Portland, OR (Jensen 
2006).   
However, at St. Luke’s Episcopal Hospital in Houston, TX, TAT was found to have 
increased by 50% (Abbass, Mhatre, Sansgiry et al. 2011).  It should be noted that these 
results should be tempered by the fact that this study was conducted during the pilot 
phase of CPOE implementation at the hospital and the CPOE orders were rarely seen by 
the pharmacists (1% of the total orders).  Further, the CPOE orders at the time may not 
have been as evident as the scanned orders in the presentation on the pharmacists’ 
monitors. 
Due to the efficiencies stated previously, medication turn-around time has been 
found to be significantly reduced after the implementation of a CPOE system. 
   
Time and Motion Comparisons 
 A systematic review of the literature was performed spanning 1966 to 2004 
regarding the time efficiency of physicians and nurses using electronic health records 
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(EHR) (Poissant, Pereira, Tamblyn et al. 2005).  Three of the articles reviewed included 
comparisons of CPOE and non-CPOE time.  Among their findings, the amount of time 
which physicians spent on prescribing in a CPOE setting versus a non-CPOE setting 
averaged an increase of 98.1% to 328.6% per shift.  The weighted average for these 
three studies yielded a 238.4% increase.  The CPOE system was inefficient for the 
physicians compared to not using CPOE. 
 In a thesis from 2011, a time and motion study similar to this study was 
conducted regarding pharmacist workflow (Cox 2011).  The amount of time spent by 
pharmacists in a CPOE versus a non-CPOE hospital pharmacy was observed.  Twenty-
four hours were observed in each setting.  In terms of the average amount of time spent 
for each observed hour in percent, by activity, (non-CPOE vs. CPOE, respectively) was as 
follows: clinical (7% vs. 12%); distributive (81% vs. 72%); administrative (10% vs. 14%); 
and miscellaneous (3% vs. 2%). 
 To our knowledge, no study has been published in a peer-reviewed article 
regarding the impact of time spent by pharmacists in a non-CPOE versus a CPOE setting. 
 
Time and Motion Studies 
 The modern version of the time and motion study began with the industrial 
organization wherein management would conduct studies to assess the productivity and 
efficiency of its workforce (De Cock 2012).  The direct measurement of the time taken 
for observed tasks was aimed at increasing production and efficiency by optimizing an 
organization’s workflow. 
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 Relatively recently, time and motion studies have been used in the healthcare 
industry.  There are two general methods of observation for time and motion studies: 1) 
self-reporting; and 2) continuous observation.  In a study performed in 2000, continuous 
observation (which is the method used in this study) was found to be more accurate 
than self-reporting (Burke, Wilson, Donahue et al.  2000).  In 2004, a continuous 
observation time and motion study was conducted comparing the amount of time taken 
by physicians reviewing patient records before and after implementation of electronic 
health records (EHR) (Pizziferri, Kittler, Volk et al.  2004).  This study also used an 
Access® (Microsoft Corp., Redmond, WA) database similar to the instrument used in this 
study.  This helps to strengthen the validation of the instrument used in this study. 
 At St. Luke’s Episcopal Hospital in Houston, TX, a time and motion study was 
performed, comparing the amount of time taken by nurses for the medication 
administration process before and after bedside barcode administration system (BCMA) 
(Dwibedi, Sansgiry, Frost et al.  2012).  That study revealed the effect of the 
implementation of a technological intervention in a healthcare setting. 
 A time and motion study can be a valuable tool for evaluating the effect of the 
implementation of an intervention in the healthcare field.  Very little research has been 
done regarding pharmacist workflow following the implementation of a technological 
intervention using a time and motion study, which is the objective of this study. 
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Theoretical Model 
 The theoretical model used was based on the model proposed by Avedis 
Donabedian (Donabedian 1988) and is outlined below. 
 
Theory of the Model 
 Donabedian’s theory related to healthcare quality and its measurement.  At its 
core, the model offers three categories of healthcare quality:  
1) Structure.  This category encompasses the material resources, human 
resources, and organizational structure used to perform any process. 
2) Process.  The process includes all of the tasks involved for the work of 
interest. 
3) Outcome.  The outcome of the process being investigated. 
The theory states that the structure influences the process, which, in turn, influences 
the outcome.  If either the structure or the process is improved, the outcome has an 
increased likelihood of improving.  Refer to Figure 1 for a graphical representation of the 
Donabedian model. 
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Figure 1.  The Donabedian Model 
 
Application of the Model 
 For this study, the structure category is the technological intervention, namely 
CPOE.  The process includes all of the tasks performed by the pharmacists of interest.  
The outcome is the amount of time spent on each activity by the pharmacists.  Refer to 
Figure 2 for a graphical representation of the application of the model. 
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Figure 2.  Application of the Model 
 
Operationalization of the Model 
 The final model of interest in this study involves the measurement of the effect 
of the technological intervention (CPOE) on the amount of time spent on each activity 
by the order entry pharmacist.  The “process” category was deleted in order to identify 
the effect of the technological intervention on the outcome.  The hypothesis (H) is that 
the implementation of CPOE could have an effect on the amount of time spent by the 
pharmacist for each of the four activities, comprised of 37 tasks.  The independent 
variable is either non-CPOE or CPOE.  The covariates are the four different hospital 
pharmacies and the two time periods.  The dependent variables are the amount of time 
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spent by the pharmacist for the four activities and the 37 tasks.  Refer to Figure 3 for a 
graphical representation of the operationalization of the model. 
 
Figure 3.  Operationalization of the Model 
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Hypothesis 
 Based on the theoretical model and previous literature, the following hypothesis 
is proposed: 
H:  There is a difference in pharmacist time spent across four activities in 
a CPOE versus a non-CPOE setting: 
1) Clinical; 
2) Distributive; 
3) Administrative; and 
4) Miscellaneous. 
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Chapter 3 
Methods 
 This chapter relates the methods of the study.  An overview of the design will be 
followed by an in-depth explanation of the specific methods used.  The preparation for 
the study will be described, followed by the data collection process, statistical 
hypothesis, and analysis. 
 
Study Design 
 A representation of the study design outline is in Figure 4.  Ultimately, the 
difference in time spent in the four activities will be compared for non-CPOE and CPOE. 
 
 
Figure 4.  Study Design Outline 
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Setting 
 Memorial Hermann Healthcare System was the hospital system wherein this 
study was conducted.  As of 2012, Memorial Hermann Healthcare System (MHHS) was 
the largest not-for-profit healthcare system in Texas (Memorial Hermann Healthcare 
System 2012).  It consisted of twelve hospitals (among other facilities) which served in 
and around the Houston area.  Six of these hospitals were named among the Nation’s 
100 Top Hospitals list by Thomson Reuters in 2012.  Three of these award-winning 
hospitals were included in this study: Memorial Hermann Memorial City Medical Center, 
Memorial Hermann The Woodlands Hospital, and Memorial Hermann Southeast 
Hospital.  Memorial Hermann Katy Hospital had been named to the same list in 2011.  
Refer to Table 2 for the number of beds by department by hospital and case mix indexes 
by hospital. 
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Table 2.  Hospital Summary: Number of Beds by Department and Case Mix Indexes 
 
 
The four hospital pharmacies involved in the study are further described as 
follows.  The first, Memorial Hermann Memorial City Medical Center, was the site of the 
intervention of interest.  For the first time period, Memorial City was considered to be 
non-CPOE.  CPOE was implemented after the completion of the first set of observations 
at that site, and over five months prior to the start of the second time period 
observations for that pharmacy.   For the purposes of this study, it will be referred to as 
the intervention site. 
 Memorial Hermann The Woodlands Hospital was the control site.  It was non-
CPOE for both time periods of observation. 
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 There were two treatment control sites for this study, both of which had 
implemented CPOE previously.  Memorial Hermann Katy Hospital was treatment control 
1.  It had used CPOE for over 5 years before the first time period observations started.  
Memorial Hermann Southeast Hospital was treatment control 2.  It had used CPOE for 
over 19 months prior to the first time period observations started.   A schematic 
representation is shown in Figure 5 of the experimental design. 
 
 
Figure 5.  Schematic Diagram of the Enhanced Pretest-Posttest Control Group 
Experimental Design 
 
Intervention Defined 
 The intervention for this study was the implementation of CPOE.  The Memorial 
Hermann Healthcare System (MHHS) information technology structure was the same for 
all of its hospitals.  Cerner Millenium® (Cerner Corp., Kansas City, MO) was the hospital-
wide information system.  All pharmacy orders (either CPOE or non-CPOE) went through 
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PharmNet®, which was a Cerner application.  If an order was a handwritten non-CPOE 
order, it was first scanned by nursing through Pyxis® Connect (CareFusion Corp., San 
Diego, CA) and then entered manually into PharmNet® by the pharmacist.  If an order 
was a CPOE order, the order was entered directly by the provider and transmitted in 
real time through the PharmNet® system for pharmacist verification.   The system is 
summarized graphically in Figure 6. 
 
 
Figure 6.  Memorial Hermann Healthcare System Pharmacy Information Technology 
Structure 
 
Within the Cerner Millenium® system, the basic difference in processing the non-
CPOE orders and the CPOE orders by the pharmacist is the transcription of the orders 
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required for those which are non-CPOE.  Both kinds of orders are still processed within 
the PharmNet® application by the pharmacist.   
The implementation of CPOE at a site involved no additional training on the part 
of the pharmacists since they already used the PharmNet® system.  The implementation 
of CPOE rather had to do with the tremendous preparation and training by hospital and 
pharmacy management, physicians, nursing, and the information technology 
department for a concerted effort to switch from the traditional handwritten orders to 
the direct entry of orders on the part of the providers.   
Each pharmacy observed could not be considered entirely non-CPOE nor 
considered entirely CPOE.  Even at a non-CPOE site, some CPOE orders were processed, 
and the opposite was also true.  For instance, at the non-CPOE control site, the 
Emergency Department was already using CPOE.  Similarly, at all of the CPOE sites, the 
Total Parenteral Nutrition orders (TPNs) were scanned to the pharmacy and then 
entered by the pharmacist into PharmNet®.  For the purposes of this study, a non-CPOE 
site and a CPOE site were defined by which system was used predominantly.   
 
Human Subject Research 
 In order to comply with the rules and regulations required for studies involving 
human subjects, the following process was involved prior to the commencement of data 
collection.  An Institutional Review Board (IRB) was applied for and granted through the 
University of Houston’s Division of Research Committee for the Protection of Human 
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Subjects.  Written approval was also granted by an authorized Systems Executive 
representing the Memorial Hermann Healthcare System.  
The data collection assistant completed the Health Insurance Portability and 
Accountability Act (HIPAA) Privacy Rule training through the Memorial Hermann system 
prior to any data collection.  All data collection was conducted and recorded in 
compliance to the HIPAA Privacy Rule, protecting all patients and subjects privacy.  No 
patient information was used or recorded as a part of this study, nor was there any 
interaction of the researcher and any patient.    
A letter of consent to participate in research was given to each pharmacist prior 
to formally requesting permission for that pharmacist to be included in the study.  Refer 
to Appendix A for a copy of the letter of consent to participate in research.  All collected 
data was stored in a password protected file in a password protected laptop computer, 
with access reserved only for the data collection assistant.   
 
Sample Size Determination 
 The software G*Power® was used to determine the sample size a priori (Faul, 
Erdfelder, Lang et al.  2007).  The calculations for each specific test factors in the 
following variables in order to calculate the required sample size:  
1) The effect size: small, medium, or large; 
2) The probability of Type I error: α; 
3)  The power required. 
 34 
 
For the purposes of this study: a medium effect size was used;  an α of 0.05 was used, 
and the power was 0.95.  The results of these calculations as well as the actual effect of 
a previous study similar to this are found below (Cox 2011).  The results are found in 
Table 3. 
 
Table 3.  Sample Size Calculation Results Performed a priori 
 
 
As a conservative measure, a sample size of 300 was used to ensure adequate 
power.   
 
Inclusion and Exclusion Criteria 
 The subjects who were included in the study were order entry pharmacists who 
worked in the central pharmacy for each particular hospital.  Only one pharmacist was 
observed for each one hour period, beginning at the start of each clock hour. 
 Excluded subjects were clinical pharmacists and pharmacists who had been 
employed by Memorial Hermann for less than 30 days.  A one-hour time period of data 
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collected was not included in the observations if there was greater than 25% (15 
minutes for each one-hour period) of combined time in the miscellaneous activity for 
each one-hour period.  This was determined on an a priori basis, in order to gather as 
much data as possible for value-added activities (clinical, distributive, and 
administrative), while minimizing the amount of non-value-added activity (defined by 
the miscellaneous activity). 
 
Activities and Tasks Defined 
 In an article published in 2006 regarding pharmacist workflow and productivity, 
four major activities performed by hospital pharmacists were listed (Gupta, Wojtynek, 
Walton et al.  2006).  The four activities were as follows: clinical, drug dispensing, 
management, and other.  In another study, after consultation with pharmacy 
management and clinical pharmacists, the four activities were similarly defined as: 
clinical, distributive, administrative, and miscellaneous (Cox 2011).   It is the latter list of 
activities into which all pharmacist tasks were grouped for this study.  Similarly, the list 
of tasks defining each of these activities for the Cox study was used as a benchmark for 
the pilot study performed with this research.  While remaining predominantly intact, 
this task list was modified to capture some different tasks observed in this study’s four 
pharmacies.  Refer to Appendix B for the definition for each task. 
There are some tasks which could not be observed, such as: personal judgment, 
decision-making, and other similar tasks.  As an example, if a pharmacist was typing a 
work-related email, it could have been possible that he or she was also internally 
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evaluating a clinical intervention.  Since there was no outwardly observed action which 
would indicate this internal thought process, this particular task would have been 
recorded as the email task.  Therefore, collected data was recorded based on 
observable actions. 
Following is a discussion of each activity. 
 
Clinical Activity 
 This activity was designed to capture all tasks which were clinical in nature.  
While the tasks composing this activity are relatively unambiguous, one could argue that 
there are many more tasks performed by the order entry pharmacist which could also 
qualify as being clinical in nature, such as the review of a particular chemotherapy order 
or consulting with a nurse about a particular patient’s medications.  However, for this 
study, the more conservative definition of clinical work was used.  Refer to Table 4 for 
the list of clinical activity tasks. 
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Table 4.  Clinical Activity Task list 
 
Distributive Activity 
 This activity was designed to capture all tasks which were distributive in nature.  
This is the activity where the majority of the order entry pharmacist’s time is spent.  It 
includes all tasks associated with: order entry and order verification; discussions with 
nurses, physicians, technicians, and other pharmacists regarding the distribution of 
medications to the hospital floors; checking of orders prior to distribution to the floors; 
and similar tasks relating to the distribution of medications to the floors.  Refer to Table 
5 for the list of distributive activity tasks. 
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Table 5.  Distributive Activity Task List 
 
Administrative Activity 
 This activity was designed to capture all tasks which were administrative in 
nature.  The administrative activity was essentially all of the other tasks which were 
neither clinical nor distributive in nature, but still value-added tasks.  The largest 
percentage of time in this activity was spent performing the following tasks: work-
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related emails; discussions with pharmacy management; other administrative tasks; and 
documentation duties.  Refer to Table 6 for the list of administrative activity tasks. 
 
Table 6.  Administrative Activity Task list 
 
 
Miscellaneous Activity 
 This activity was designed to capture all non-value-added tasks.  This included 
only personal time.  Refer to Table 7 for the miscellaneous activity task. 
 
Table 7.  Miscellaneous Activity Task List 
 
Data Collection 
 All data collection was performed by a single individual – the data collection 
assistant.  Prior to including any pharmacist as a subject for the study, the data 
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collection assistant handed a copy of the letter of consent to participate in research to 
the pharmacist.  The data collection assistant reiterated that there would be no 
consequence (positive or negative) for either participating or not participating in the 
research and that each subject’s identity would be kept confidential should the subject 
choose to participate.  Additionally, the subject would not be required to do anything 
outside of the scope of their normal workload to be included in the study.  The data 
collection assistant answered all questions posed by the pharmacists regarding the 
study.  Once permission was granted, that pharmacist was considered to be included in 
the study sample.  Each pharmacist was assigned a number known only to the data 
collection assistant.  This number was the unique identifier used in data collection. 
 Data was collected regarding the observed pharmacists involved in the study.  
Pharmacist’s unique identifier, gender, and amount of experience within the Memorial 
Hermann system as a pharmacist were all recorded. 
Data was collected regarding the characteristics of each hospital involved in the 
study.  The number of beds, case mix indexes, and general information about the 
hospitals were recorded. 
The list of data collected from the observations for each individual task were as 
follows:  unique identification number for each observation (created by the original 
database); task identification number; start time for each task (the end time for each 
task was established by the start time for the subsequent task); date of each task; and 
comments associated with that task (if applicable).  All of these variables were collected 
in real time. 
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The following variables remained constant for each individual hour, and were 
assigned to each individual observation following the completion of all data gathering.  
At the beginning of each hour, the pharmacist identification number and pharmacist 
assignment were recorded in the comment section of the instrument.  Each pharmacist 
was given an assignment at the beginning of his or her shift.  At the intervention site, for 
example, pharmacist “A” was assigned to primarily cover the patients in certain 
departments and floors, while pharmacist “B” was assigned to different departments 
and floors.  These assignments remained the same for the entire shift.  Assignments 
could change from day to day for each pharmacist. 
The following variables remained constant for each individual day: the day 
number; the pharmacy identification number; the designation of whether the pharmacy 
was considered CPOE or non-CPOE; and the time period.  These variables were assigned 
to each individual observation following the completion of all data gathering. 
Extrapolated variables from the original data included: minutes per task (by 
finding the difference between the start time for the task and the start time for the 
subsequent task); activity (depending on the task); hour of the day; hour number; day 
number; and number of task changes per hour (determined by subtracting the 
observation number of the first task for that hour from the number of the last task for 
that hour). 
Every different task was recorded in the instrument.  In the case where multiple 
tasks were being performed by the pharmacist at one time, the data collection assistant 
would have to make a judgment as to which task was receiving more attention by the 
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pharmacist and record that task.  An example of this would be a case where the 
pharmacist was talking on the phone with a nurse and then put on hold, at which time 
the pharmacist would return to the order verification task. 
Queues were taken from the computer screens used by the pharmacist, actions 
of the pharmacist, nature of the conversations, and similar indicators.  In the rare 
instance where the data collection assistant was not able to determine which task a 
pharmacist was conducting, that entire hour was not used in the analysis. 
A further discussion on the techniques used to record the observations is in the 
Instrument section. 
 All observations were recorded by the data collection assistant on a MSI™ 
(Micro-Star International Company, Ltd., New Taipei City, Taiwan) laptop computer 
Model number MS-N014.  All collected data was stored in a password protected file in 
the password protected computer, with access reserved only for the data collection 
assistant. 
 
The Hawthorne Effect 
 As it applies to this study, the Hawthorne effect essentially states that any 
subject who is knowingly under observation will perform tasks differently than one who 
is not under observation.  In order to minimize this effect, several measures were taken.  
The data collection assistant was seated behind two or more order-entry pharmacists 
whenever possible, at a distance ranging from three to ten feet, depending on the 
layout of the pharmacy and the existing seating arrangements.  In doing so, subjects 
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could not easily determine which subject was being observed at any given time.  Every 
effort was taken by the data collection assistant to be as unobtrusive as possible once 
observations commenced.  An important aspect of reducing the Hawthorne effect was 
to have the data collection assistant be as pleasant and accommodating as possible to 
everyone in the pharmacy, especially the pharmacists.  In general, the more at ease that 
a subject is with the data collection assistant, the more a subject can concentrate on his 
or her work, thereby minimizing any additional stress or distraction of having a 
researcher recording observations.  This, in turn, allows for a more accurate recording of 
the order entry pharmacist’s actions by the data collection assistant. 
 It should also be noted that each of these four pharmacies host multiple 3rd and 
4th year pharmacy students from local colleges, pharmacy residents, junior college 
students, volunteer pharmacy technicians in training, and high school students on a 
regular basis.  Several of each of these types of individuals were seen by the data 
collection assistant regularly at each of these pharmacies throughout the data collection 
process.  The order entry pharmacists at each of these hospitals were already 
accustomed to being observed and having multiple students learning the profession as 
visitors in their pharmacies.  This helped to minimize the Hawthorne effect by 
conditioning the pharmacists to being observed even before this study began. 
 
Data Collection Schedule 
The central pharmacy at each site was in continual operation (24 hours a day, 
seven days a week, and 365 days a year).  Data collection was performed from 7:00 am 
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to 5:00 pm on weekdays, in one-hour periods.  This data collection schedule was 
determined based on four criteria.   
The first criterion was that the schedule had to capture a block of time during 
which a large volume of orders would be processed by the order entry pharmacists.  
This period of time was selected in part because many order entry pharmacists and 
pharmacy directors stated that this time would capture a great amount of data which 
was relevant to the study.  These statements were later confirmed, according to data 
presented to the data collection assistant from treatment control 2, for time period 1.  
This ten hour period of time was consistently among the top third of ten hour periods of 
time in terms of order actions processed by the entire pharmacy. 
The second criterion was that multiple pharmacists could be observed during 
this time period, in order to sample as many different pharmacists as possible.  This time 
period was chosen to have at least as many opportunities for observations of multiple 
pharmacists as any other ten hour time period. 
The third criterion was that the time period had to be a minimum span of four 
hours and a maximum span of ten hours, with more hours being preferable.  This would 
help to ensure the broadest coverage of the entire 24 hour day as possible.  Ten hours 
was chosen to be the maximum amount of time that could be accurately captured by 
the data collection assistant without any breaks. 
The fourth criterion was that at least three observations needed to be conducted 
from any one hour time period, in order to ensure a representative sampling for each of 
the ten hours during the day for each time period.  In other words, a minimum of three 
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observations were required each from 7:00 am to 8:00 am, 8:00 am to 9:00 am, and so 
on, for each of the two time periods for each site.  Since four days were observed for 
each time period, this criterion was met. 
The resulting schedule was to include four ten-hour days (40 hours) per site per 
time period.  Since there were four sites and two time periods, a total of 320 hours 
would be gathered before deletion of any hours in order to comply with the minimum 
sample size determined to be 300. 
After the go-live of CPOE at a pharmacy, it has been estimated to take one to 
three months for the providers to become familiar enough with it to become 
comfortable.  Also, during this time, the pharmacists can be subject to more questions 
on the part of the providers as to specific questions regarding the CPOE system.  It is for 
this reason that the lag in time from the go-live date at the intervention facility to the 
second set of observations during time period 2 at that site was over five months.  This 
was the largest time lag between any of facilities from time period 1 to time period 2 
observations, so as to allow as much time as possible to pass, thereby capturing more 
accurate “pre” and “post” measurements at this site.  Since all of the other facilities had 
no changes to either their CPOE or non-CPOE status, shorter lags between their 
respective Time Period 1 and Time Period 2 observations were allowed, the shortest of 
which was two and a half months. 
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Sample Selection 
 Pharmacists were randomly selected to be observed for each hour of the day 
prior to arrival of the data collection assistant.  Other considerations were taken into 
account when selecting which pharmacist was to be observed for a particular hour: shift 
schedules for different pharmacists; lunch schedules for different pharmacists; other 
pharmacist responsibilities (extended meetings or special projects which were not 
typical duties of the order entry pharmacist); and the location of the pharmacist relative 
to the data collection assistant.  All of these factors were subject to change at any time, 
so the data collection assistant had to adapt throughout the day as conditions changed. 
 
Instrument 
 The instrument used was originally developed by Partners® Healthcare System 
for the Agency for Healthcare Research and Quality (AHRQ) and was designed to 
capture and store time and motion data (AHRQ 2012).  The instrument is an Access® 
(Microsoft Corp., Redmond, WA) database.  It was modified from its original version to 
the current version to accommodate this study’s tasks and activities by an independent 
consultant.  Refer to Figure 7 for the screenshot of the modified instrument. 
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Figure 7.  Screenshot of the Instrument 
 
 At the beginning of each day of observations, the data collection assistant would 
arrive approximately five to ten minutes early to prepare for the data collection.  The 
data collection assistant turned the laptop on and the laptop time was synchronized 
with the pharmacy computer time (if necessary).  Then the instrument was opened.  The 
data collection assistant clicked the “Now” button to update the instrument time (based 
on the laptop time), followed by clicking on the “Start” button, and followed by clicking 
on the “Add New Record” button.  By clicking on the “Add New Record” button, the 
original observation was added to the record (with its start time which was updated 
with the “Now” button) and the end time was defined as the start time of the new 
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observation, which was updated with the “Add New Record” button.  This new 
observation was ready to have a task assigned, so the data collection assistant clicked 
on that task – “Order Entry”, for example.  An additional comment could be typed in the 
comment box at this time.  As soon as a new task began, the “Add New Record” was 
clicked and the new task was selected. 
 A silent alarm on the data collection assistant’s phone was set for the 59th 
minute of every hour of the daily observations to prompt the data collection assistant to 
complete that hour’s observations in approximately one minute and begin the next 
hour’s observations at the exact second of the start of the new hour. 
 At the end of a day of observations, the data collection assistant clicked the 
“Finish” button, then clicked the “Add New Record” button, then exported the database 
to a secure Excel® (Microsoft Corp., Redmond, WA) spreadsheet.  The data collection 
assistant would then click the “Close” button in the instrument.  The same database was 
used for the entirety of the study.  Exporting the data to an Excel® spreadsheet daily 
served as a backup of the data and after the final export, the data was expanded to 
include the complete set of variables listed in the Data Collection section, prior to the 
statistical analysis, which was performed using SAS® version 9.3 (SAS Institute Inc., Cary, 
NC). 
 
Pilot Study 
 Subsequent to the required permissions by the university and the hospital 
administration, a pilot study was conducted.  The data collection assistant spent the first 
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day with a Memorial Hermann pharmacy Operations Manager who was an expert with 
both the Memorial Hermann pharmacy system and the instrument.  This training was 
sufficient for the data collection assistant to become familiar with pharmacist workflow 
and the instrument.  The final hour of the first day was spent having the expert validate 
the data collection assistant’s data collection of an order entry pharmacist as a 
simulation of all subsequent data collection.  This process allowed many of the order 
entry pharmacists to become familiar with the data collection assistant and the research 
being conducted.  It also allowed for the data collection assistant to not only become 
more familiar with the data collection process and the order entry pharmacists, but to 
have the study’s data collection process validity tested by an expert. 
As a part of the pilot study, the data collection assistant visited each of the four 
pharmacies over multiple days.  Observations were conducted and recorded at this time 
as a part of the pilot study.  These observations were not included with the study 
observations.  
 
Statistical Analysis 
The measured variables used in the analysis are listed in Table 8.  Analyses would 
be conducted separately for the activity and task dependent variables.  The activity 
dependent variables will be analyzed using adjusted values (controlling for the 
independent variables and the covariates), since there is sufficient data to have 
sufficient non-zero values representing each of the four activities.  The task dependent 
variables will not be adjusted, as there would be too many tasks with zero values.  In 
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other words, not every hour had values for each of the 37 tasks.  It is for this reason, 
that unadjusted means would be used for the task analysis. 
 
Table 8.  Measured Variables 
 
The Access® database was exported to Excel® spreadsheet format, as previously 
described.  The extrapolated and repeated variables previously described were entered 
into the spreadsheet.  The final spreadsheet was imported into SAS® version 9.3 for the 
analysis.  Refer to Appendix C for the codebook. 
Descriptive statistics were determined and reported, regarding the hospitals, 
pharmacies, sample population, and general observation data.  Summary statistics of 
each hour were calculated by activity and task.  The data was then checked for 
normality with a comparison of the means and medians of the CPOE versus the non-
CPOE activities.   
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If a normal distribution was found, a MANCOVA analysis would be performed 
using the variables in Table 8 for the activity analysis.  Post-hoc ANCOVAs would be 
calculated with Scheffe adjustments. 
If a non-normal distribution was found, non-parametric regressions would be 
calculated.  The predicted values would be saved and then tested for significance using 
Wilcoxon rank-sum tests (the p-value of the Wilcoxon 2-sided t-approximation was 
used). 
Many of the tasks will be non-parametric, due to low representation of certain 
tasks.  For this reason, all tasks were analyzed using Wilcoxon rank-sum tests. 
In all tests, a p-value of less than 0.05 was considered statistically significant. 
 
Statistical Hypothesis 
 The statistical hypothesis is as follows: 
H0 : Multivariate Test: 
 τ Non-CPOEi = τ CPOEi = 0 
 There is no statistically significant difference between the time spent by 
pharmacists across the four activities. 
 Where i is defined as: 1) Clinical Activity 
    2) Distributive Activity 
    3) Administrative Activity 
    4) Miscellaneous Activity 
 τ = Multivariate mean minutes / hour  spent by pharmacists 
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Chapter 4 
Results 
 Results of the data collection are presented in this chapter.  Descriptive statistics 
results are followed by the statistical analysis, including tests for normality and 
correlation tests.  Since the data would be found to be non-parametric, non-parametric 
linear regressions are presented, by activity and sub-activity (additionally, the 
distributive activity was analyzed by sub-activities to give insight into the activity where 
the majority of the pharmacist’s time is spent).  The predicted values of the activity and 
sub-activity analysis were analyzed.  The chapter will end with the analysis of the 
individual tasks. 
 
Descriptive Statistics 
 The data collection period spanned from April 2, 2012 to October 2, 2012.  A 
total of 340 hours of observations were conducted, of which 311 hours met the 
inclusion criteria.  A total of 114 hours were spent observing non-CPOE sites, while 197 
hours were spent observing CPOE sites.  Refer to Table 9 for overall study statistics. 
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Table 9.  Study Statistics 
 
 
 The number of different pharmacists observed at each site ranged from 9 to 11, 
most were female (ranging from 55% to 82% at each pharmacy).  The number of 
different types of order entry pharmacists ranged from 4 to 6.  Refer to Table 10 for 
pharmacist characteristics. 
 
Table 10.  Pharmacist Characteristics 
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 A total of 9831 different tasks were recorded.  The number of tasks per hour 
ranged from 5 to 62.  The three non-CPOE sets of observations had the lowest means, 
with 27.1, 25.4, and 25.7 tasks per hour.  Refer to Table 11 for the tasks per hour 
summary and the number of hours recorded at each site by time period. 
 
Table 11.  Number of Tasks, Hours, and Tasks/Hour by Site and Time Period 
 
 
Normality Test 
 A comparison between the means and medians, by activity, was performed to 
test the data for normality.  The results of this comparison of the means and medians of 
the activities by hour are in Table 12.   
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Table 12.  Test for Normality Comparing Means and Medians by Activity, in Minutes / 
Hour 
 
  
The test for normality resulted in the determination that the data was non-
parametric.  Only the means and the medians found in the distributive activity could be 
considered to have a normal distribution.  None of the other comparisons between the 
means and the medians were close enough to be considered to have a normal 
distribution.  This result rendered the MANCOVA and associated post-hoc comparisons 
to be not applicable to this data.  Instead, non-parametric linear regressions and 
analysis were performed.   
 
Correlation Tests 
 Prior to performing the non-parametric linear regression, the variables were first 
tested for correlation.  First, the correlation between the dependent and independent 
variables was conducted.  Refer to Table 13 for the results of this correlation test. 
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Table 13.  Correlation test – Dependent versus Independent Variables 
 
 
 The Pearson correlation coefficients were all less than 0.15, which was 
acceptable.  
Next, the correlation among the independent variables was conducted.  Refer to 
Table 14 for the results of this correlation test. 
 
Table 14.  Correlation Test – Independent Variables 
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None of the correlations between the dependent and the independent variables, 
nor any of the correlations amongst the independent variables were large enough to 
warrant further investigation.  Therefore, there was no issue with multicollinearity and 
the regression could proceed.   
 
Non-Parametric Linear Regression by Activity 
 The general linear regression model was: 
 
ACTIVITY = β0 + β1 (CPOE_STATUS) + β2 (HOSPITAL) + β3 (TIME_PERIOD) 
 
where:  ACTIVITY =  Time spent (in minutes per hour) for clinical,  
distributive, administrative, or miscellaneous 
activities 
  CPOE_STATUS = Either CPOE or non-CPOE (CPOE was the base) 
  HOSPITAL =   Intervention, control, treatment control 1, or 
     treatment control 2 site (Dummy variables were 
created to capture each parameter) (the 
intervention site was the base) 
  TIME_PERIOD = Time Period 1 or Time Period 2 (Time Period 1 was 
     the base) 
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The results of the non-parametric regressions for the four activities are as 
follows.  Refer to Table 15 for the results of the clinical activity non-parametric 
regression. 
 
Table 15.  Non-Parametric Regression – Clinical Activity 
 
 Holding all other variables in the model constant, a CPOE site had approximately 
1.7 minutes/hour less time in the clinical activity than a non-CPOE site.  This result was 
not statistically significant. 
Refer to Table 16 for the results of the distributive activity non-parametric 
regression. 
 
Table 16.  Non-Parametric Regression – Distributive Activity 
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Holding all other variables in the model constant, a CPOE site had approximately 
6.4 minutes/hour more time in the distributive activity than a non-CPOE site.  This result 
was statistically significant. 
Refer to Table 17 for the results of the administrative activity non-parametric 
regression. 
 
Table 17.  Non-Parametric Regression – Administrative Activity 
 
Holding all other variables in the model constant, a CPOE site had approximately 
4.4 minutes/hour less time in the administrative activity than a non-CPOE site.  This 
result was statistically significant. 
Refer to Table 18 for the results of the miscellaneous activity non-parametric 
regression. 
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Table 18.  Non-parametric Regression –Miscellaneous Activity 
 
Holding all other variables in the model constant, a CPOE site had approximately 
0.3 minutes/hour less time in the miscellaneous activity than a non-CPOE site.  This 
result was not statistically significant. 
 
Non-Parametric Linear Regression by Sub-Activity 
The distributive activity was where the majority of the order entry pharmacist’s 
time was spent (approximately ¾ of the observed time).  To further explore this activity, 
it was divided into three sub-activities, and then non-parametric linear regressions were 
performed for each sub-activity.  Order entry was the first sub-activity.  It consisted of 
all tasks associated with non-CPOE: order entry, chemo mixing review, and TPN mixing 
review.  The second sub-activity was order verification.  It consisted of the only task 
associated with CPOE:  order verification.  The third sub-activity was other.  It consisted 
of all the other tasks comprising the distributive activity.   
Refer to Table 19 for the results of the non-parametric regression for the order 
entry sub-activity. 
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Table 19.  Non-Parametric Regression – Order Entry (Distributive Sub-Activity) 
 
Holding all other variables in the model constant, a CPOE site had approximately 
5.3 minutes/hour less time in the order entry sub-activity than a non-CPOE site.  This 
result was not statistically significant. 
Refer to Table 20 for the results of the non-parametric regression for the order 
verification sub-activity. 
 
Table 20.  Non-Parametric Regression – Order Verification (Distributive Sub-Activity) 
 
Holding all other variables in the model constant, a CPOE site had approximately 
11.7 minutes/hour more time in the order verification sub-activity than a non-CPOE site.  
This result was statistically significant. 
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Refer to Table 21 for the results of the non-parametric regression for the other 
sub-activity. 
 
Table 21.  Non-Parametric Regression – Other (Distributive Sub-Activity) 
 
Holding all other variables in the model constant, a CPOE site had approximately 
0.04 minutes/hour more time in the other sub-activity than a non-CPOE site.  This result 
was not statistically significant. 
  
Activity and Sub-Activity Analysis 
The predicted values from all the above regressions were saved and compared 
by using the Wilcoxon rank-sum test, along with the original unadjusted means.  The 
results of these tests are shown below.   
Refer to Table 22 for the results of the Wilcoxon rank-sum tests across the 
activities, comparing non-CPOE and CPOE. 
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Table 22.  Average Time (Minutes) Spent by Pharmacists per Hour, by Activity 
 
 
 With the comparison of the analysis of the unadjusted means and medians side 
by side the predicted means and medians, the p-values all became either statistically 
significant or more statistically significant with the predicted values versus the 
unadjusted values.  After CPOE implementation, less time was spent in the clinical, 
administrative, and miscellaneous activities, while more time was spent in the 
distributive activity.   
Refer to Table 23 for the results of the Wilcoxon rank-sum tests across the 
distributive sub-activities, comparing non-CPOE and CPOE. 
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Table 23.  Average Time (Minutes) Spent by Pharmacists per Hour, by Distributive Sub-
Activity 
 
 
With the comparison of the analysis of the unadjusted means and medians next 
to the predicted means and medians, the p-values all became more statistically 
significant with the predicted values versus the unadjusted values.  After CPOE 
implementation, less time was spent in the order entry sub-activity, while more time 
was spent in the order verification and other sub-activities. 
 
Task Analysis 
 The analysis for each individual task was performed using the Wilcoxon rank-sum 
test, designed for non-parametric data.   
Refer to Table 24 for the results of the clinical activity task analysis. 
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Table 24.  Average Time (Minutes) Spent by Pharmacists per Hour - Clinical Tasks 
 
  
 The results of the clinical activity task analysis revealed three of the ten tasks to 
be statistically significant.  The tasks which were statistically significantly different were:  
clinical intervention (approximately 0.3 minutes/hour less for CPOE versus non-CPOE 
sites); drug information (approximately 0.4 minutes/hour more for CPOE versus non-
CPOE sites); and other-clinical (approximately 1.3 minutes/hour less for CPOE versus 
non-CPOE sites). 
Refer to Table 25 for the results of the distributive activity task analysis. 
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Table 25.  Average Time (Minutes) Spent by Pharmacists per Hour - Distributive Tasks 
 
 
The results of the distributive activity task analysis revealed twelve of the 
seventeen tasks to be statistically significant.  Some of the tasks which were statistically 
significantly different were:  order entry (approximately 15.0 minutes/hour less for 
CPOE versus non-CPOE sites); order verification (approximately 13.4 minutes/hour more 
for CPOE versus non-CPOE sites); clarification-nurse (approximately 0.9 minutes/hour 
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more for CPOE versus non-CPOE sites); tech check-non IV room (approximately 0.8 
minutes/hour more for CPOE versus non-CPOE sites); pyxis fill cart check (approximately 
1.0 minutes/hour more for CPOE versus non-CPOE sites); and other-distributive 
(approximately 0.9 minutes/hour more for CPOE versus non-CPOE sites).   
Other findings were as follows.  On average: fewer order entry tasks were 
conducted by the CPOE versus the non-CPOE sites (5.25 tasks/hour versus 7.95 
tasks/hour); more than four times the number of order verification tasks were 
conducted by the CPOE versus the non-CPOE sites (7.76 tasks/hour versus 1.75 
tasks/hour); and more than three times the number of TPN order reviews were 
conducted by the CPOE versus the non-CPOE sites (0.95 tasks/hour versus 0.29 
tasks/hour). 
Refer to Table 26 for the results of the administrative activity task analysis. 
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Table 26.  Average Time (Minutes) Spent by Pharmacists per Hour - Administrative Tasks 
 
 
The results of the administrative activity task analysis revealed one of the nine 
tasks to be statistically significant.  That task was: other-administrative (approximately 
0.6 minutes/hour more for CPOE versus non-CPOE sites).  On average, the other-
administrative task was conducted almost twice as often for the CPOE versus the non-
CPOE sites (0.52 tasks/hour versus 0.28 tasks/hour). 
Refer to Table 27 for the results of the miscellaneous activity task analysis. 
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Table 27.  Average Time (Minutes) Spent by Pharmacists per Hour - Miscellaneous Tasks 
 
 
The result of the miscellaneous activity task analysis revealed the personal time 
task to be statistically significant (approximately 1.2 minutes/hour more for CPOE versus 
non-CPOE sites).  On average, the personal time task was conducted approximately half 
as often for the CPOE versus the non-CPOE sites (0.54 tasks/hour versus 1.00 
tasks/hour). 
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Chapter 5 
Discussion and Conclusion 
 This chapter will explore the results in further detail with a discussion and 
possible implications as to the reasons for certain findings.  This will be followed by 
some recommendations for future studies.  The limitations and strengths of the study 
will be outlined before the final conclusion. 
  
Discussion 
 Twenty-nine hours could not be used for the study due to any number of 
reasons (see Table 9).  The most common reason was the unanticipated absence of the 
order entry pharmacist being observed, typically for the lunch break.  This resulted in 
the loss of many hours, though the original criteria of using only hours which had 75% of 
value-added work remained intact.  This allowed for more robust analysis of the actual 
workflow of the order entry pharmacist, rather than an account which included more 
personal time. 
 To a great extent, the pharmacist characteristics were quite comparable across 
all four sites (refer to Table 10).  The number of pharmacists, the number of female 
pharmacists, and the types of order entry pharmacists were very similar.  The only 
apparent difference was in the experience of the pharmacists where the mix at the 
control site had a greater number of pharmacists with over 10 years of pharmacist 
experience. 
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 The number of different tasks performed per hour varied greatly (refer to Table 
11).  As a general rule, the fewer number of tasks that a person has to perform in any 
given hour, the more productive that person can be.  While not always the case, the 
fewer number of tasks performed in any given hour can be thought of as the individual 
having fewer interruptions, either external or internal.  Fewer interruptions usually 
translates to greater productivity. 
 Each pharmacy observed operated in a different and unique way, depending on 
the pharmacy management’s discretion, the daily assignments of the pharmacists, the 
unique needs of the hospital, the volume of medications processed by each pharmacy, 
the mix of individuals in the pharmacy (for example: pharmacists, pharmacy technicians, 
management, and volunteers), individual work ethic, physical layout of the pharmacy, 
and similar factors.   
It was interesting to observe the lowest means of tasks performed in each hour 
were during the three sets of observations where CPOE had not been implemented.  
Further study of these results should be performed. 
 All of the individual activities had relatively low (<0.15) correlations with the 
independent variable and the covariates (refer to Table 13).  Similarly, none of the 
independent variables were correlated any more that 0.56 (between the CPOE status 
and the Hospital, which was anticipated, since only the intervention site changed CPOE 
status during the study and all others CPOE status remained constant) (refer to Table 
14).   The other two correlations were very low: 0.02 and 0.05, though they were not 
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statistically significant.  These results were a positive indication that the correct 
variables were chosen to predict the dependent variables. 
 In reviewing the results of the non-parametric linear regression models found in 
Tables 15-21, the results showed that each of the independent variables was statistically 
significant for both the regressions by activity and the distributive sub-activities.  While 
none of the models had 100% of the parameters statistically significant, five of the 
seven models had 50% or more of their parameters considered to be statistically 
significant.  Indeed, comparing the predicted means and medians with the unadjusted 
means and medians, one can see that the non-parametric regressions were very well 
representative of the data (refer to Table 22). 
 Holding all other variables in the model fixed, the implementation of CPOE 
resulted in approximately 1.7 minutes/hour less of clinical work than that of a non-CPOE 
site.  This was not statistically significant (refer to Table 15).  Unfortunately, this was not 
the result that was hoped for.  Instead of freeing up more pharmacist time for clinical 
work, less time was spent in this activity. 
 From Table 16, the CPOE sites had approximately 6.4 minutes/hour more time 
spent in the distributive activity than those which had not implemented CPOE, holding 
all other variables in the model fixed.  This was statistically significant.  This is a relative 
large amount of time difference between CPOE and non-CPOE (approximately 10% of 
each hour).  One can suspect that if the CPOE sites had less time spent in this activity, 
more time could be freed for additional clinical work.  
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 From Table 17, the CPOE sites had approximately 4.4 minutes/hour less time 
spent in the administrative activity than those which had not implemented CPOE, 
holding all other variables in the model fixed.  This was statistically significant. 
From Table 18, the CPOE sites had approximately 0.3 minutes/hour less time 
spent in the miscellaneous activity than those which had not implemented CPOE, 
holding all other variables in the model fixed.  This was not statistically significant. 
It should be noted that these results are not seemingly consistent with the Cox 
study in 2011 (Cox 2011).  In that study, two different sites were observed, one had 
implemented CPOE and the other was non-CPOE.  The statistically significant findings 
included greater amount of time spent in the clinical and administrative activities, and a 
lesser amount of time in the distributive activity for the CPOE versus the non-CPOE site.  
The miscellaneous activity had a lesser amount of time for the CPOE versus the non-
CPOE site, though this finding was not statistically significant.  These findings did not 
take into account the other variables which were controlled for in this study.  Also, since 
the sites were different, it is difficult to determine the extent to which the 
organizational structure and other factors in each pharmacy played a role in these 
results.   
The Cox study, however, did include data regarding the number of order actions 
and order verifications performed for the hours observed.  There was a greater number 
(approximately 1.7 times) of order actions performed by the CPOE site versus the non-
CPOE site.  There was a greater number (approximately 1.4 times) of order verifications 
(completed orders) performed by the CPOE site versus the non-CPOE site.  Both of these 
 74 
 
findings were statistically significant.  While the number of order actions and order 
verifications for this study’s sample were not available at the time of this publication, 
one would expect similar findings in terms of productivity for this study’s CPOE versus 
non-CPOE sites.  A subsequent study which includes this data will be performed in the 
future. 
 In reviewing the results of the breakdown of the distributive activity, the CPOE 
sites had approximately 5.3 minutes/hour less time spent in the order entry sub-activity 
than those which had not implemented CPOE, holding all other variables in the model 
fixed (refer to Table 19).  Even though this was not statistically significant, the finding is 
logical.  Fewer orders would be processed by order entry after CPOE was implemented, 
resulting in less time required for this task. 
 Similarly, the results in Table 20 agree with this same logic.  Holding all other 
factors in the model fixed, the CPOE sites had approximately 11.7 minutes/hour more 
time in the order verification sub-activity.  This finding was statistically significant.   
While there was approximately 5.3 fewer minutes/hour spent in the order entry 
sub-activity, it was more than offset by the approximately 11.7 additional minutes/hour 
spent in the order verification sub-activity.  That translates to a net increase in the 
distributive activity of approximately 6.4 additional minutes/hour due to order 
verification alone.  The amount of order actions and order verifications would need to 
be analyzed for these study hours to investigate if the additional time spent in the 
distributive category is proportional to the number of orders actually completed by the 
pharmacists. 
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 The results in Table 21 show that there is an almost imperceptible increase 
(approximately 0.04 minutes/hour) in the amount of time spent at the CPOE sites versus 
non-CPOE sites for the other sub-activity.   This finding was not statistically significant.  
The fact that it was not statistically significant, coupled with the small difference in this 
other sub-activity, means that the increased time spent by the CPOE sites in the 
distributive activity was due solely to the net difference in time spent by pharmacists 
performing order verifications (CPOE) over order entry (non-CPOE) tasks.  This means 
that after the implementation of CPOE, more time was spent in the distributive activity 
due to the increased time spent on CPOE orders than non-CPOE orders. 
  Assuming that more orders can be processed in a shorter amount of time with 
the implementation of CPOE, more time should be spent on the other sub-activity tasks, 
due to the greater volume.  However, virtually the same amount of time was spent on 
these other tasks, holding all other factors in the model fixed.  This lack of increase 
should be investigated further. 
 With the analysis of the unadjusted means and medians side by side the 
predicted means and medians (refer to Tables 22-23), the p-values all became either 
statistically significant or more statistically significant.  After CPOE implementation, less 
time was spent in the clinical, administrative, and miscellaneous activities, while more 
time was spent in the distributive activity.  After CPOE implementation, less time was 
spent in the order entry sub-activity, while more time was spent in the order verification 
and other sub-activities.  It should be noted that the difference found here in the 
predicted values of the other sub-activity shows a difference, while the results of the 
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non-parametric linear regression did not.  This is due to the different number of hours 
spent at the different sites, each with different independent variables. 
 In Tables 24-27, the number of tasks which were significant for each activity 
were as follows: 3 – clinical (3%); 12 – distributive (70%); 1 – administrative (11%); and  
1 – miscellaneous (100%).  In total, 17 of the 37 (46%) were found to be statistically 
significantly different.  Highlights of tasks of statistical significance include: clinical 
intervention (non-CPOE > CPOE by approximately 0.3 minutes/hour); drug information 
(CPOE > non-CPOE by approximately 0.4 minutes/hour); other-clinical (non-CPOE > 
CPOE by approximately 1.3 minutes/hour); clarification-nurse (CPOE > non-CPOE by 
approximately 0.9 minutes/hour); tech check – non-IV room (CPOE > non-CPOE by 
approximately 0.8 minutes/hour); other-administration (CPOE > non-CPOE by 
approximately 0.6 minutes/hour); and personal time (non-CPOE > CPOE by 
approximately 1.22 minutes/hour). 
 Of particular interest was the greater amount of time spent by non-CPOE versus 
CPOE in the tasks of clinical intervention and other-clinical.  The CPOE sites, however, 
had more time spent in drug intervention and e-MAR/lab review, as well as a greater 
quantity of these tasks per hour than the non-CPOE sites (1.22 tasks/hour versus 0.55 
tasks/hour and 1.51 tasks/hour versus 1.04 tasks/hour, respectively).  If one of the goals 
post-CPOE implementation was to increase the amount of clinical work in terms of time, 
this was not found to be the case.  It appears that CPOE actually decreased the amount 
of time spent by order entry pharmacists in clinical work.  It is also possible that this 
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could to be a case of differences in emphasis by individual pharmacy management.  The 
true cause is beyond the scope of this study, but worthy of investigation. 
 
Implications 
 The implementation of CPOE can certainly have a positive influence regarding 
patient safety.  However, management needs to remain vigilant for unintended 
consequences after its implementation.  Just because a system has become automated 
or more computerized does not necessarily mean that all outcomes will be improved.   
 There are many factors which influence outcomes regarding the implementation 
of CPOE in a hospital pharmacy setting.  One is the software itself.  Different software 
packages will render different results in different settings.  Proper research into which 
type of software package will be the most advantageous for a particular setting needs to 
be performed by hospital and pharmacy management prior to making any decision. 
 A corollary to this recommendation is the proper vetting and customization of 
order sets by the physicians, nurses, and the pharmacists.  An order set which requires 
even slight modifications every time it is used, will affect the workflow and productivity 
of the pharmacist in having to alter it at each occurrence.  Likewise, if a physician is 
consistently sending an order which needs to be modified, not only will pharmacist 
productivity suffer, but there may be possible consequences to the patient if the 
modification is missed. 
The organizational structure of the pharmacy has a tremendous influence on 
pharmacist productivity.  Such policies as “Tech-Check-Tech”, where pharmacy 
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technicians are allowed to check each other on Pyxis fills, for instance, can alleviate the 
workload of the pharmacist.  Also, a pharmacy which has a “buffer”system, wherein one 
pharmacist is the lead person charged with: interacting with the nursing or physicians 
regarding incoming calls; performing technician checks on first doses; and fielding 
pharmacy technician issues; can alleviate interruptions to other order entry 
pharmacists.  This could make these other order entry pharmacists more productive.  
Separating the hospital by floor or department can also help to increase familiarity of 
the pharmacist with that aspect of the hospital and therefore improve productivity for 
the pharmacist. 
Prior to implementation of any technological intervention, metrics need to be 
put in place to assess the progress of such implementation efforts.  In terms of 
productivity of CPOE implementation regarding the pharmacists, such metrics can be: 
time spent per activity and the number of order actions and order verifications 
performed in a certain time. 
It needs to be understood that productivity, while a worthy goal, is obviously no 
tradeoff for performing all aspects of pharmacist duties well.  Management needs to be 
diligent in making any changes in the pharmacy setting.  The implementation of a CPOE 
system is no exception.  Unintended consequences need to be anticipated as much as 
possible.  Management needs to constantly monitor and verify proper and successful 
implementation of these systems in order to assure successful outcomes for the future. 
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Recommendations for Future Study 
Many studies act as a catalyst for future studies.  This study is no different.  
Following are some recommendations for further research. 
Additional time and motion studies regarding the workflow of order entry 
pharmacists in both in these pharmacies and in different settings are recommended.  
Additional data may help to give insight as to the extent that certain variables 
determine workflow. 
The effect of the number of tasks performed by the order entry pharmacist per 
hour on workflow and productivity are still largely unknown.  It was interesting to 
observe the lowest means of tasks performed per hour were during the three sets of 
observations where CPOE had not been implemented.  Further investigation into these 
results should be performed. 
While the number of order actions and order verifications for this study’s sample 
were not available at the time of this publication, one would expect similar findings to 
the Cox study in terms of productivity.  A subsequent analysis which includes this data 
should be performed in the future. 
It appears that CPOE actually decreased the amount of time spent by order entry 
pharmacists in clinical work.  It is also possible that this could to be a case of differences 
in emphasis by individual pharmacy management.  The true cause is beyond the scope 
of this study, but worthy of investigation. 
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Limitations 
 While every effort was given to minimize the limitations of this study, there are 
some which exist.  This study’s limitations include: 
 The generalizability of this study is limited to the hospital system, the study sites, 
and the CPOE system implemented.  While it is not unreasonable to extrapolate 
general trends found in this study, caution should be used before doing so; 
 The observations were limited to the hours of 7:00 am to 5:00 pm during 
weekdays, so the findings may or may not represent any other times; 
 The Hawthorne effect, though minimized as much as possible; 
 Possible observer bias, as with any time and motion study; 
 The temporary unavailability of productivity measures, such as the number of 
order entries and order verifications per pharmacist per hour; 
 Unable to account for different hospital order severity; and 
 Not an entirely random selection process, since other considerations were taken 
into account, as previously listed. 
Strengths 
 The strengths of this study are substantial.  They include: 
 A relatively large sample size; 
 The study design: an Enhanced Pretest-Posttest Control Group design, including 
controls for the control and controls for the treatment; 
 Use of a single observer, therefore limiting any possible observer bias to be at 
least consistent. 
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Conclusion 
 The implementation of computerized provider order entry (CPOE) affected 
pharmacist workflow across every activity: clinical, distributive, administrative, and 
miscellaneous.  Less time was spent in the clinical, administrative, and miscellaneous 
activities, while more time was spent in the distributive activity after CPOE 
implementation. 
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Chapter 6 
Summary 
 Technological interventions have, and will continue to, affect the hospital 
pharmacy.  Computerized provider order entry (CPOE) has the promise to deliver 
improved outcomes for patients, while at the same time affecting the workflow of the 
order entry pharmacist. 
 CPOE is the electronic entry of orders by an authorized provider.  These orders 
were traditionally handwritten and communicated to the pharmacy by one of many 
methods (scanning is the current method) for processing and dispensing.  However, with 
a CPOE system, a provider will directly enter the orders into the computer.  These 
orders are typically available to the pharmacist for verification immediately upon 
completion by the provider. 
 The objective of this research was to perform a time and motion study to 
quantify the amount of time which an inpatient order entry pharmacist spends on 
various activities in a non-CPOE versus a CPOE setting. 
 The study design was an experimental, enhanced pretest-posttest, prospective, 
time and motion study.  Order entry pharmacists from four inpatient pharmacies were 
observed over two separate time periods.  All four pharmacies were within the 
Memorial Hermann Healthcare System, located in the Houston, Texas area.  The 
intervention pharmacy was observed first as a non-CPOE pharmacy and then later, after 
CPOE had been implemented.  The control pharmacy was non-CPOE for both time 
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periods.  There were two treatment control pharmacies, both of which had previously 
implemented CPOE for both time periods. 
 A Microsoft Access® database was used as the recording instrument.  It was 
originally designed to capture time and motion observations.  It was modified to record 
the tasks of interest in this study. 
 In an effort to quantify the differences in workflow between CPOE and non-CPOE 
pharmacies, comparisons of the amount of time spent by the order entry pharmacist in 
each of four different activities (comprised of the 37 tasks): clinical, distributive, 
administrative, and miscellaneous; were conducted.   
 The order entry activity was where the majority (approximately ¾) of the 
pharmacist time was spent.  This activity was divided into three sub-activities: order 
entry; order verification; and other - for further analysis. 
 The data was tested for normality and found to be not normally distributed.  
Therefore, non-parametric tests would be used in the analysis.  Non-parametric linear 
regressions were performed for the activities and the sub-activities.  Predicted means 
were generated from these regressions and analyzed using Wilcoxon rank-sum tests. 
 Analysis of individual tasks was performed using Wilcoxon rank-sum tests. 
 All descriptive and statistical analysis was performed using SAS® version 9.3.  
Statistical significance was set at 0.05. 
 A total of 340 hours of observation were conducted, of which 311 hours met the 
inclusion criteria.  A total of 9831 tasks were recorded and 42 order entry pharmacists 
were observed. 
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The non-parametric linear regression results for the activities were as follows.   
Holding all other variables in the model constant, a CPOE site had approximately 
1.7 minutes/hour less time in the clinical activity than a non-CPOE site.  This result was 
not statistically significant.   
Holding all other variables in the model constant, a CPOE site had approximately 
6.4 minutes/hour more time in the distributive activity than a non-CPOE site.  This result 
was statistically significant.   
Holding all other variables in the model constant, a CPOE site had approximately 
4.4 minutes/hour less time in the administrative activity than a non-CPOE site.  This 
result was statistically significant. 
Holding all other variables in the model constant, a CPOE site had approximately 
0.3 minutes/hour less time in the miscellaneous activity than a non-CPOE site.  This 
result was not statistically significant. 
The non-parametric linear regression results for the sub-activities were as 
follows.   
Holding all other variables in the model constant, a CPOE site had approximately 
5.3 minutes/hour less time in the order entry sub-activity than a non-CPOE site.  This 
result was not statistically significant. 
Holding all other variables in the model constant, a CPOE site had approximately 
11.7 minutes/hour more time in the order verification sub-activity than a non-CPOE site.  
This result was statistically significant. 
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Holding all other variables in the model constant, a CPOE site had approximately 
0.04 minutes/hour more time in the other sub-activity than a non-CPOE site.  This result 
was not statistically significant. 
The results of the analysis of the predicted means and medians for the activities 
and the distributive sub-activities were as follows. 
Regarding the activities, after CPOE implementation, less time was spent in the 
clinical, administrative, and miscellaneous activities, while more time was spent in the 
distributive activity.  These results were all statistically significant. 
Regarding the sub-activities, after CPOE implementation, less time was spent in 
the order entry sub-activity, while more time was spent in the order verification and 
other sub-activities.  These results were all statistically significant. 
Some of the important results of the analysis of the individual tasks were as 
follows. 
The tasks which were statistically significantly different were:  clinical 
intervention (approximately 0.3 minutes/hour less for CPOE versus non-CPOE sites); 
drug information (approximately 0.4 minutes/hour more for CPOE versus non-CPOE 
sites); other-clinical (approximately 1.3 minutes/hour less for CPOE versus non-CPOE 
sites); order entry (approximately 15.0 minutes/hour less for CPOE versus non-CPOE 
sites); order verification (approximately 13.4 minutes/hour more for CPOE versus non-
CPOE sites); clarification-nurse (approximately 0.9 minutes/hour more for CPOE versus 
non-CPOE sites); tech check-non IV room (approximately 0.8 minutes/hour more for 
CPOE versus non-CPOE sites); pyxis fill cart check (approximately 1.0 minutes/hour more 
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for CPOE versus non-CPOE sites); other-distributive (approximately 0.9 minutes/hour 
more for CPOE versus non-CPOE sites);  and other-administrative (approximately 0.6 
minutes/hour more for CPOE versus non-CPOE sites). 
Other findings were as follows.  On average: fewer order entry tasks were 
conducted by the CPOE versus the non-CPOE sites (5.25 tasks/hour versus 7.95 
tasks/hour); more than four times the number of order verification tasks were 
conducted by the CPOE versus the non-CPOE sites (7.76 tasks/hour versus 1.75 
tasks/hour); and more than three times the number of TPN order reviews were 
conducted by the CPOE versus the non-CPOE sites (0.95 tasks/hour versus 0.29 
tasks/hour). 
 These results were very insightful.  Each pharmacy observed operated in a 
different and unique way, depending on the pharmacy management’s discretion, the 
daily assignments of the pharmacists, the unique needs of the hospital, the volume of 
medications processed by each pharmacy, the mix of individuals in the pharmacy (for 
example: pharmacists, pharmacy technicians, management, and volunteers), individual 
work ethic, physical layout of the pharmacy, and similar factors.  This had a direct effect 
on the results. 
 The result of the clinical activity regression analysis was that approximately 1.7 
minutes/hour less were spent by CPOE versus non-CPOE sites.  Unfortunately, this was 
not the result that was hoped for.  Instead of freeing up more pharmacist time for 
clinical work, less time was spent in this activity. 
 87 
 
The result of the distributive activity regression analysis was that the CPOE sites 
had approximately 6.4 minutes/hour more time than those which had not implemented 
CPOE, holding all other variables in the model fixed.  This is a relative large amount of 
time difference between CPOE and non-CPOE (approximately 10% of each hour).  One 
can suspect that if the CPOE sites had less time spent in this activity, more time could be 
freed for additional clinical work.  
 The result of the regressions of the three distributive sub-activities was a net 
increase in time spent in order verification over order entry for CPOE versus non-CPOE.  
The other sub-activity was not a major factor.  This means that after the implementation 
of CPOE, more time was spent in the distributive activity due to the increased time 
spent on CPOE orders than non-CPOE orders.  Without the burden of interpreting 
handwriting, one would have expected the opposite to be true.  Further research needs 
to be performed to discover if a proportionally greater number of order actions and 
order verifications were conducted as a result of this increase in time, therefore 
justifying the increase. 
 In conclusion, the results showed that there was less time spent in the clinical, 
administrative, and miscellaneous activities, while more time was spent in the 
distributive activity after CPOE implementation. 
It needs to be understood that productivity, while a worthy goal, is obviously no 
tradeoff for performing all aspects of pharmacist duties well.  Management needs to be 
diligent in making any changes in the pharmacy setting.  The implementation of a CPOE 
system is no exception.  Unintended consequences need to be anticipated as much as 
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possible.  Management needs to constantly monitor and verify proper and successful 
implementation of these systems in order to assure successful outcomes for the future. 
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CONSENT TO PARTICIPATE IN RESEARCH 
 
Dear Pharmacist, 
 
We are requesting your participation in a research project titled “The Impact of Computer Physician Order 
Entry on Medication Order Processing and Workflow Efficiency by Pharmacists: A Time in Motion Study”.  
The project is undertaken and conducted by a graduate student as part of his thesis work requirement, 
under the guidance of Dr. Sujit Sansgiry, Associate Professor, Division of Pharmacy Administration and 
Public Health, Department of Clinical Sciences and Administration, College of Pharmacy, University of 
Houston. 
 
The purpose of the study is to quantify the different activities performed by pharmacists and their 
duration over a specified time period.  We anticipate collecting data randomly on the different activities 
performed by the pharmacist.  You will be one of approximately 30 pharmacists invited to participate in 
this study.  If you agree to participate, a data collection assistant will proceed with the observation.  Your 
activities should not be affected in any way during the observation. 
 
There are no foreseeable risks associated with this project to you or your patients.  While you will not 
directly benefit from participation, we anticipate that the project may help investigators better 
understand pharmacy workflow.  The indirect benefit would be improved workflow efficiency in hospitals. 
 
Your participation is voluntary and you may refuse to participate or withdraw at any time without penalty 
or loss of benefits to which you are otherwise entitled.  You may also refuse to answer any question.  A 
decision to participate or not or to withdraw your participation will have no effect on your standing.  Your 
participation in this project is confidential and no identifiers will be recorded in this study. 
 
The results of this study may be published in professional and/or scientific journals.  It may also be used 
for educational purposes or for professional presentations.  However, no individual subject will be 
identified.  Only aggregate data will be reported. 
 
If you have any questions, you may contact Mark Hatfield at 713-795-8342 or Dr. Sujit S. Sansgiry at 713-
795-8392.  Any questions regarding your rights as a research subject may be addressed to the University 
of Houston Committee for the Protection of Human Subjects at 713-743-9204.  All research projects 
that are carried out by investigators at the University of Houston are governed by requirements of the 
University and the Federal Government. 
 
Please keep this page for your records.  If you agree to participate, please indicate so to the Observer.  
Your cooperation is greatly appreciated.  Thank you for your help by participating in this study. 
 
 
Sincerely, 
 
 
Mark Hatfield     Sujit S. Sansgiry, PhD 
Graduate Student    Faculty Advisor 
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Clinical Activity 
Clinical Intervention:   Documentation of a clinical intervention in the MedKeeper® 
system. 
Direct Patient Care:  Direct care involved in the presence of the patient. 
Drug Information:  Researching pharmaceutical and therapeutic drug information with 
either reference books or internet references. 
E-MAR / Lab Review:  Referencing patient electronic medical record or lab results. 
Consult Rph – Clinical:  Consultation with another pharmacist regarding clinical aspects. 
Pt. Consult – Discharge:  Consultation with a patient regarding discharge medication(s) 
instructions. 
Pt. Consult – Warfarin:  Consultation with a patient regarding Warfarin medication 
instructions. 
Rounds:  Rounds spent consulting with patients, nurses, and / or physicians. 
Physician’s Order Form:  Filling out a Physician’s Order Form on the physician’s behalf 
for future verification by the physician. 
Other – Clinical:  Any other clinical activity not included in any other clinical task. 
 
Distributive Activity 
Order Entry:  Manual entry of medication orders via written (scanned) or verbal 
communication.  (Non-CPOE orders.) 
Order Verification:  Any of the actions performed on orders received through the 
PharmNet® system.  (CPOE orders.) 
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Clarification – Nurse:  Communication with a nurse, typically by phone, regarding 
distributive aspects. 
Clarification – Physician:  Communication with a physician, typically by phone, regarding 
distributive aspects. 
Tech Check: Non-IV room:  Physical verification of medications prepared by a pharmacy 
technician by the pharmacist in the central pharmacy. 
Tech Check: IV room:  Physical verification of medications prepared by a pharmacy 
technician by the pharmacist in the IV room. 
Medication Prep / Delivery:  Physical preparation or delivery (typically using the hospital 
tubing system) of medications by the pharmacist. 
IT support:  Pharmacist request for support of the hospital IT department.  
Consult Rph – Distributive:  Consultation with another pharmacist regarding distributive 
aspects. 
Consult Tech:  Consultation with a pharmacy technician regarding distributive aspects. 
Chemo Order Review:  Order entry of Chemo orders. 
Chemo Mixing Check:  Physical verification of Chemo order(s) prepared by a pharmacy 
technician. 
TPN Order Review:  Order entry of TPN orders. 
TPN Mixing Check:  Physical verification of TPN order(s) prepared by a pharmacy 
technician. 
Pyxis Fill Cart Check:  Physical verification of medications intended to re-fill the Pyxis 
machines on the hospital floors. 
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SCIP / HOP Review:  Inpatient and outpatient surgery order reviews and order entry.  
Also includes meeting time with surgery team. 
Other – Distributive:  Any other distributive activity not included in any other 
distributive task. 
 
Administrative Activity 
Meeting:  Attendance at any formal meeting. 
Huddle:  Attendance at the meeting for all pharmacy personnel (pharmacy 
management, order entry pharmacists, and pharmacy technicians).  Can be daily or 
weekly – at the discretion of pharmacy management. 
Shift Report:  Preparation of shift summary reports required by pharmacy management. 
Schedule:  Checking of the pharmacy schedule, discussion of the pharmacy schedule, or 
work on creating the pharmacy schedule. 
Emails:  Work related emails. 
Q and A:  Questions and answers with pharmacy management regarding pharmacy 
operations. 
Teaching / Mentoring:  The active teaching or mentoring of a pharmacist in training, a 
resident pharmacist, or a student pharmacist. 
Documentation:  The act of filling out a form which is non-clinical and non-distributive; 
filing of paperwork; printing; or scanning. 
Other – Administrative:  Any other administrative activity not included in any other 
administrative task. 
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Miscellaneous Activity 
Personal time:  Any non-work related time. 
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Variable Description Va lues
Excel_ID Observation number (ID) in Microsoft Excel Varies
Access_ID Observation number (ID) in Microsoft Access instrument Varies
Sitting_No Number different sessions (Not used) 1 to 79
Keep_Obs Keep or Delete the observation 0 = Delete observation
1 = Keep observation
Date Date in DD-MMM-YY format Varies
Day_No Day of observation 1 to 39
Time Time of day in HH:MM:SS format Varies
Elapsed_time Time in HH:MM:SS format of time spent per observation Varies
Minutes Time in decimal format of time spent per observation Varies
TC Time Code - Hour of the day 1 = 7am to 8am
2 = 8am to 9am
3 = 9am to 10am
4 = 10am to 11am
5 = 11am to 12pm
6 = 12pm to 1pm
7 = 1pm to 2pm
8 = 2pm to 3pm
9 = 3pm to 4pm
10 = 4pm to 5pm
11 = 5pm to 6pm
Hr Hour of observation 1 to 340
Retain_Hr Retain or Delete the hour of observation 0 = Delete hour
1 = Retain hour
Post Pre or Post intervention observation 0 = Pre
1 = Post
HID Hospital ID 1 = Memorial City
2 = The Woodlands
3 = Katy
4 = Southeast
CMI Medicare Case Mix Index, by hospital 1.6264 = Memorial City
1.6764 = The Woodlands, Southeast, and 2 other hospitals
                  combined (not specific to TW or SE)
1.5216 = Katy
CPOE CPOE or Non-CPOE pharmacy 0 = Non-CPOE
1 = CPOE
Experiment_ID Experiment ID 1 = Memorial City, Pre, Non-CPOE
2 = Memorial City, Post, CPOE
3 = The Woodlands, Pre, Non-CPOE
4 = The Woodlands, Post, Non-CPOE
5 = Katy, Pre, CPOE
6 = Katy, Post, CPOE
7 = Southeast, Pre, CPOE
8 = Southeast, Post, CPOE
Beds Number of hosptial beds, per hosptial 426 = Memorial City
252 = The Woodlands
142 = Katy
274 = Southeast
Census Hospital Census, by day Varies
Ch_Census Change in Hospital Census from the previous day, in decimal form Varies
((current day census - previous day census) / (current day census))
Pct_Cap Percent of hospital capacity, in decimal form (Census / Beds) Varies
Rph Pharmacist ID 1 to 63
Gender Pharmacist Gender 0 = Male
1 = Female
Exp Pharmacist institutional experience 0 = 0 to 1 year
1 = 1 to 10 years
2 = 10+ years
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Variable Description Va lues
Rph_Type Pharmacist type of responsibilities (varies by shift, HID) 1 = A = Pharmacist A, day shift - Memorial City
2 = B = Pharmacist B, day shift - Memorial City
3 = A2 = Pharmacist A, evening shift - Memorial City
4 = B2 = Pharmacist B, evening shift - Memorial City
5 = N = Night pharmacist - Memorial City
6 = 1 = Pharmacist 1 - The Woodlands
7 = 2 = Pharmacist 2 - The Woodlands
8 = 3 = Pharmacist 3 - The Woodlands
9 = IV = Pharmacist IV - The Woodlands
10 = OE = Pharmacist OE - The Woodlands
11 = T = Pharmacist Other - The Woodlands
12 = 0630 = Pharmacist 0630 - Katy
13 = 0800 = Pharmacist 0800 - Katy
14 = 1330 = Pharmacist 1330 - Katy
15 = 1430 = Pharmacist 1430 - Katy
16 = 0700 = Pharmacist 0700 - Southeast
17 = 1000 = Pharmacist 1000 - Southeast
18 = 1430 = Pharmacist 1430 - Southeast
19 = IV = Pharmacist IV - Southeast
20 = 3B = Pharmacist 3B - Southeast
OA Number of Order Actions per hour, per pharmacist Varies
OE Number of Order Entries per hour, per pharmacist Varies
Task_Ch Number of different tasks per hour, per pharmacist Varies
Task Task ID 1 = Clinical Intervention documented in MedKeeper
2 = Direct Patient Care
3 = Med Therapy Recommendation (Not used)
10 = Other - Clinical Category
11 = Order Entry (non-CPOE orders)
12 = Order Verification (CPOE orders)
13 = Clarification - Nurse
14 = Clarification - Physician
15 = Technician Check
16 = Med Request (Not used)
17 = Medication Prep / Delivery
18 = Consult RPh - Distributive Category
19 = Consult Tech
20 = Meeting
21 = Shift Report
22 = Emails
23 = Q and A with Management
24 = Other - Administrative Category
25 = Drug Information research
26 = Other - Distributive Category
27 = Consult RPh - Clinical Category
28 = Technician Check in IV Room
29 = Answering Dispensing Questions (Not used)
30 = IT Support
31 = E-Mar / Lab Review
32 = Phone Triage (Not used)
33 = Pt. Consult - Discharge
34 = Pt. Consult - Warfarin
35 = Pt. Consult - Other
36 = Rounds
37 = Physician's Order Form
38 = Chemo Order Review & Entry
39 = Chemo Mixing Check
40 = TPN Order Review & Entry
41 = TPN Mixing Check
42 = Pyxis Fill Cart Check
43 = SCIP / HOP Review (IP & OP surgeries)
44 = Teaching / Mentoring
45 = Documentation
46 = Huddle
47 = RPh Schedule - review or management
63 = Internet (Not used)
64 = Personal Time
65 = Colleague/Staff for Non-Pt. (Not used)
71 = Other - Miscellaneous Category (Not used)
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Variable Description Va lues
Categ Activity 1 = Clinical Activity
2 = Distributive Activity
3 = Administrative Activity
4 = Miscellaneous Activity
Cat1 Minutes spent in Clinical Activity by observation Varies
Cat2 Minutes spent in Distributive Activity by observation Varies
Cat3 Minutes spent in Administrative Activity by observation Varies
Cat4 Minutes spent in Miscellaneous Activity by observation Varies
Cat2_OE Minutes spent in Distributive Activity by observation Varies
for all tasks involving Order Entry (includes Tasks 11, 38, & 40)
Cat2_OV Minutes spent in Distributive Activity by observation Varies
for all tasks involving Order Verification (includes Task 12 only)
Cat2_OE_OV Minutes spent in Distributive Activity by observation Varies
for all tasks involving Order Entry and Verification, combined
(includes Tasks 11, 12, 38, & 40) (Not used)
Cat2_Oth Minutes spent in Distributive Activity by observation Varies
for all tasks NOT involving either Order Entry or Order Verification
Calls Number of incoming calls to pharmacy per observation Varies
Calls_ans_Rph Number of incoming calls answered by a pharmacist Varies
Rph_OD Number of pharmacists on duty, by hour Varies
Tech_OD Number of technicians on duty, by hour Varies
Comment Comments made by observer, by observation Varies
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